Autopsy report · NCT03222089
Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC
Cause of deathOther
“Another study enrolling the similar group of patient are ongoing”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Fujian Cancer Hospital
- Sponsor type
- Government (non-US federal)
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Irinotecan; Oxaliplatin; Levoleucovorin; 5-FU; GM-CSF; IL-2
- Participants
- 0
- Sites
- 1
- Countries
- China
Trials that died the same way
- Clinical, Electrophysiological and Biological Diagnostic Criteria of Sensory Neuronopathies
“Start of a new study concerning the same patients” - An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study
“Enrolled requested number of patients and completed study. In analysis” - Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria
“the patients are now followed in another hospital. The study is discontinued” - Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
“The study was incorporated in another study.” - Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery
“for difficulty to enroll patients in the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.